Reevaluating potassium supplementation in pediatric DKA: Is routine KPO₄ use necessary?

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Diabetes Management

Background:

• Diabetic ketoacidosis (DKA) is a critical complication in pediatric type 1 diabetes.
• Effective management of DKA involves addressing electrolyte disturbances, especially potassium levels.
• Current treatment protocols often include potassium phosphate (KPO₄) for supplementation.

Purpose of the Study:

• To evaluate the clinical outcomes of using potassium chloride (KCl) alone versus combined KCl and KPO₄ supplementation in pediatric DKA.
• To determine if omitting KPO₄ impacts acidosis resolution or electrolyte balance.
• To assess the safety and efficacy of simplified potassium supplementation strategies.

Main Methods:

• Retrospective cohort study of 113 pediatric DKA cases over 13 years.
• Comparison of outcomes between patients receiving KCl only versus KCl + KPO₄.
• Key outcome measures included serum electrolytes, acidosis resolution time, and transition to subcutaneous insulin.

Main Results:

• No significant differences in acidosis severity or resolution time between groups.
• Incidence of hypokalemia and hyperchloremia was similar regardless of KPO₄ use.
• Omission of KPO₄ did not lead to adverse electrolyte imbalances or delayed treatment.

Conclusions:

• Potassium chloride (KCl) monotherapy is a viable alternative to combined KCl and potassium phosphate (KPO₄) in pediatric DKA.
• Simplifying potassium supplementation with KCl alone does not compromise patient outcomes.
• Further prospective studies are recommended to validate these findings in pediatric DKA management.